Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
Tribute to Steph Smith – October 2010
December 6, 2018
Avoiding Respiratory Infections
November 29, 2018
Marijuana use and aspergillosis
November 23, 2018
Gardening
November 22, 2018
Dehumidifiers
November 16, 2018
Anti-allergen products
November 16, 2018
Air conditioning units and Aspergillus
November 15, 2018
… remove mould from my home?
November 9, 2018
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video